SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-16-013189
Filing Date
2016-05-12
Accepted
2016-05-12 07:31:45
Documents
54
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0316_soligenix.htm 10-Q 455891
2 CERTIFICATION f10q0316ex31i_soligenix.htm EX-31.1 13355
3 CERTIFICATION f10q0316ex31ii_soligenix.htm EX-31.2 12571
4 CERTIFICATION f10q0316ex32i_soligenix.htm EX-32.1 4870
5 CERTIFICATION f10q0316ex32ii_soligenix.htm EX-32.2 4432
  Complete submission text file 0001213900-16-013189.txt   3043037

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE sngx-20160331.xml EX-101.INS 540666
7 XBRL SCHEMA FILE sngx-20160331.xsd EX-101.SCH 35295
8 XBRL CALCULATION FILE sngx-20160331_cal.xml EX-101.CAL 31521
9 XBRL DEFINITION FILE sngx-20160331_def.xml EX-101.DEF 112006
10 XBRL LABEL FILE sngx-20160331_lab.xml EX-101.LAB 328537
11 XBRL PRESENTATION FILE sngx-20160331_pre.xml EX-101.PRE 207677
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 161641652
SIC: 2834 Pharmaceutical Preparations